Avram Miller's most recent trade in Renovaro Biosciences Inc was a trade of 978,261 Option to Purchase Shares of Common Stock done . Disclosure was reported to the exchange on Aug. 23, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Renovaro Biosciences Inc | Avram Miller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Aug 2024 | 978,261 | 978,261 | - | - | Option to Purchase Shares of Common Stock | |
| Renovaro Biosciences Inc | Avram Miller | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Aug 2024 | 833,333 | 166,667 (0%) | 1% | 0 | Common Stock | |
| Renovaro Biosciences Inc | Avram Miller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2024 | 18,634 | 18,634 | - | - | Option to purchase shares of common stock |